Indicator Metadata
- Summary View
- Detailed View
Name |
Incidence of End-Stage Kidney Disease (ESKD), by Age Group, Sex, Province, Rate per Million Population |
Short/Other Names |
Not applicable |
Description |
All incident patients (new patients) with end-stage kidney disease who began renal replacement therapy (RRT) (either dialysis or renal transplantation) for the first time in the calendar year |
Interpretation |
Increasing incidence rates over time have important implications for resources, disease management and the need for kidney donation. |
HSP Framework Dimension |
Health System Outcomes: Improve health status of Canadians |
Areas of Need |
Not applicable |
Geographic Coverage |
All provinces/territories except Quebec |
Reporting Level/Disaggregation |
National, Province/Territory, Breakdown by sex, breakdown by age categories |
Indicator Results |
Name |
Incidence of End-Stage Kidney Disease (ESKD), by Age Group, Sex, Province, Rate per Million Population |
Short/Other Names |
Not applicable |
Description |
All incident patients (new patients) with end-stage kidney disease who began renal replacement therapy (RRT) (either dialysis or renal transplantation) for the first time in the calendar year |
Calculation: Description |
Counts and rates are based on patients registered during a given calendar year in a Canadian facility. Patients who began RRT for ESKD outside of Canada but are subsequently treated in Canada are included in prevalence counts but not incidence counts. |
Calculation: Geographic Assignment |
Place of service |
Calculation: Type of Measurement |
Rate - Per 1,000,000 |
Calculation: Adjustment Applied |
None |
Calculation: Method of Adjustment |
Not applicable |
Denominator |
Description: |
Numerator |
Description: |
Rationale |
Tracking incidence is important to determine the number of new cases of patients beginning RRT for ESKD each year. Tracking incidence can quantify how the need for intervention may change over time. There are significant costs associated with treating this patient group. |
Interpretation |
Increasing incidence rates over time have important implications for resources, disease management and the need for kidney donation. |
HSP Framework Dimension |
Health System Outcomes: Improve health status of Canadians |
Areas of Need |
Not applicable |
Targets/Benchmarks |
Not applicable |
References |
Nesrallah GE, Mustafa RA, Clark WF, et al. Canadian Society of Nephrology 2014 Clinical Practice Guideline for Timing the Initiation of Chronic Dialysis. CMAJ. 2014;186(2):112-117. Available at
http://www.cmaj.ca/content/186/2/112 Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for Management of Chronic Kidney Disease. CMAJ. 2008;179(11):1154-1162. Available at http://www.cmaj.ca/content/179/11/1154 |
Data Sources |
CORR |
Available Data Years |
Type of Year: |
Geographic Coverage |
All provinces/territories except Quebec |
Reporting Level/Disaggregation |
National, Province/Territory, Breakdown by sex, breakdown by age categories |
Update Frequency |
Every year |
Indicator Results |
Web Tool: |
Updates |
Not applicable |
Caveats and Limitations |
The indicator is based on voluntary data submitted to CORR from facilities across Canada. Submission of data for patients beginning RRT for ESKD is not mandatory. Records submitted with unknown sex are not included in these totals. Data from Quebec was not included because of significant under-reporting between 2011 and 2018, which may lead to biased results. |
Trending Issues |
An overview of under-reporting of incident ESKD cases can be found in Data Quality Documentation for Users: Canadian Organ Replacement Register, 2009 to 2018 Data. |
Comments |
Not applicable |